סינגולייר 4 מ"ג גרנולות לקטנטנים

Land: Israel

Sprache: Hebräisch

Quelle: Ministry of Health

Wirkstoff:

MONTELUKAST AS SODIUM 4 MG

Verfügbar ab:

MERCK SHARP & DOHME ISRAEL LTD

ATC-Code:

R03DC03

Darreichungsform:

GRANULES

Verabreichungsweg:

PER OS

Hergestellt von:

MERCK SHARP & DOHME, NETHERLANDS

Therapiegruppe:

MONTELUKAST

Anwendungsgebiete:

Singulair is indicated in adult and pediatric patients 12 months of age and older for the prophylaxis and chronic treatment of asthma, including prevention of daytime and nighttime symptoms, the treament of aspirin - sensitive asthmatic patients, and the prevention of exercise - induced bronchoconstriction. Singulair is effective alone or in combination with other agents used in the maintenance treatment of chronic asthma. Singulair and inhaled corticosteroids may be used concomitatly with additive effects to control asthma or to reduce the inhaled corticosteroid dose while maintaining clinical stability.

Berechtigungsdatum:

2009-01-01